217 related articles for article (PubMed ID: 28911508)
21. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
[TBL] [Abstract][Full Text] [Related]
22. Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
Navarese EP; Kolodziejczak M; Winter MP; Alimohammadi A; Lang IM; Buffon A; Lip GY; Siller-Matula JM
Int J Cardiol; 2017 Jan; 227():644-649. PubMed ID: 27810295
[TBL] [Abstract][Full Text] [Related]
23. Acute-Phase Plasma PCSK9 Levels and Recurrent Cardiovascular Events in a Chinese Acute Myocardial Infarction Cohort.
Gao Y; Qiu Y; Wu J; Diao W; Zhang H; Wang S; Du Z; Dong J; Zhang M; Jiang L
Cardiology; 2018; 141(2):88-97. PubMed ID: 30423567
[TBL] [Abstract][Full Text] [Related]
24. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S
Circulation; 2002 Apr; 105(14):1650-5. PubMed ID: 11940542
[TBL] [Abstract][Full Text] [Related]
25. Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Menichelli D; Nocella C; Carnevale R; Violi F
J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27609361
[TBL] [Abstract][Full Text] [Related]
26. Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.
Carnevale R; Nocella C; Pignatelli P; Bartimoccia S; Stefanini L; Basili S; Novo M; D'Amico A; Cammisotto V; Pastori D; Violi F
Atherosclerosis; 2018 Jul; 274():29-34. PubMed ID: 29747088
[TBL] [Abstract][Full Text] [Related]
27. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
Shi J; Zhang W; Niu Y; Lin N; Li X; Zhang H; Hu R; Ning G; Fan J; Qin L; Su Q; Yang Z
Cardiovasc Diabetol; 2020 Dec; 19(1):209. PubMed ID: 33302966
[TBL] [Abstract][Full Text] [Related]
28. Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.
Pastori D; Carnevale R; Nocella C; Bartimoccia S; Novo M; Cammisotto V; Piconese S; Santulli M; Vasaturo F; Violi F; Pignatelli P;
J Am Heart Assoc; 2018 Nov; 7(22):e009509. PubMed ID: 30571484
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
[TBL] [Abstract][Full Text] [Related]
30. Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Concentration and Risk of Cardiovascular Events - Systematic Review and Meta-Analysis of Prospective Studies.
Xiao Y; Peng C; Huang W; Zhang J; Gao Y; Kim JH; Yeoh EK; Su X
Circ J; 2017 Jul; 81(8):1150-1157. PubMed ID: 28413188
[TBL] [Abstract][Full Text] [Related]
31. Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding.
Pignatelli P; Pastori D; Bartimoccia S; Menichelli D; Vicario T; Nocella C; Carnevale R; Violi F
Pharmacol Res; 2016 Nov; 113(Pt A):484-489. PubMed ID: 27693274
[TBL] [Abstract][Full Text] [Related]
32. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
[TBL] [Abstract][Full Text] [Related]
33. Family History of Atrial Fibrillation and Risk of Cardiovascular Events: A Multicenter Prospective Cohort Study.
Pastori D; Menichelli D; Lip GYH; Sciacqua A; Violi F; Pignatelli P;
Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008477. PubMed ID: 32718257
[TBL] [Abstract][Full Text] [Related]
34. [Blood Levels of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Men from Different Population Groups and Its Relation to Unfavorable Long-Term Prognosis].
Ragino YI; Astrakova KS; Shakhtshneider EV; Stakhneva EM; Gafarov VV; Bogatyrev SN; Voevoda MI
Kardiologiia; 2017 Apr; 57(4):72-76. PubMed ID: 28762908
[TBL] [Abstract][Full Text] [Related]
35. [Predictive value of plasma PCSK9 levels in acute myocardial infarction patients without reperfusion therapy for recurrence of cardiovascular events within 1 year].
Gao Y; Zhang HB; Hou LL; Wang SM
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(35):2750-2755. PubMed ID: 31550797
[No Abstract] [Full Text] [Related]
36. Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Choi IJ; Lim S; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
Am J Cardiol; 2020 Oct; 133():54-60. PubMed ID: 32798044
[TBL] [Abstract][Full Text] [Related]
37. Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials.
Yang S; Shen W; Zhang HZ; Wang CX; Yang PP; Wu QH
Cardiovasc Drugs Ther; 2023 Oct; 37(5):927-940. PubMed ID: 35511323
[TBL] [Abstract][Full Text] [Related]
38. Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study.
Xie W; Liu J; Wang W; Wang M; Qi Y; Zhao F; Sun J; Liu J; Li Y; Zhao D
Int J Cardiol; 2016 Jul; 215():293-8. PubMed ID: 27128549
[TBL] [Abstract][Full Text] [Related]
39. Platelet activation and lipid peroxidation in patients with acute ischemic stroke.
van Kooten F; Ciabattoni G; Patrono C; Dippel DW; Koudstaal PJ
Stroke; 1997 Aug; 28(8):1557-63. PubMed ID: 9259748
[TBL] [Abstract][Full Text] [Related]
40. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
Pignatelli P; Pastori D; Carnevale R; Farcomeni A; Cangemi R; Nocella C; Bartimoccia S; Vicario T; Saliola M; Lip GY; Violi F
Thromb Haemost; 2015 Mar; 113(3):617-24. PubMed ID: 25392853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
